aDepartment of Internal Medicine, Section of Infectious Disease, HIV/AIDS Program, Yale University School of Medicine, New Haven, CT;

bDepartment of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT;

cCenters for Disease Control and Prevention, Atlanta, GA; and

dConnecticut Department of Public Health, Hartford, CT.

Correspondence to: Eteri Machavariani, MD, PhD, Section of Infectious Diseases, HIV/AIDS Program, Department of Internal Medicine, Yale University School of Medicine, 135 College Street, Suite 323 New Haven, CT 06511 (e-mail: [email protected]).

Support by Division of HIV/AIDS Prevention, Centers for Disease Control and Prevention (Project U01 PS004508).

Presented at Ryan White All Title Conference; December 2018; Washington, DC; Conference on Retroviruses and Opportunistic Infections (CROI); March 2019; Seattle, WA; HIV Prevention Conference; April 2019; Atlanta GA.

The authors have no funding or conflicts of interest to disclose.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jaids.com).

The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.

The Department of Public Health Human Investigations Committee approved this research project, which used data obtained from the Department of Public Health. The Department of Public Health does not endorse or assume any responsibility for any analyses, interpretations or conclusions based on the data. The authors assume full responsibility for all such analyses, interpretations and conclusions.